Yoga for reducing tobacco cravings
Part of Mental health clinical trials.
This study tests whether yoga can help men who are dependent on tobacco reduce their cravings. If you are a male tobacco user aged 18 to 65, this trial may offer a non-medicine way to manage your urge to smoke or chew tobacco.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man between 18 and 65 years old.
- You are dependent on tobacco (determined by a simple screening test).
- You get your care at specific clinics in or around Mugalur, India.
- You have not used alcohol or other drugs in the last 3 months.
- You do not have a serious mental health condition diagnosed in the last 6 months.
- You are able to do gentle yoga postures and do not have recent heart attack, stroke, severe high blood pressure, seizures, or advanced COPD.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 study tests whether taking oral CBD can help people quit tobacco. It also checks safety and helps researchers learn how people respond to the treatment while they practice quitting.
This trial tests whether guided mindfulness meditation in virtual reality can lower cigarette cravings and help people quit smoking. It may help by reducing urges to smoke during stressful moments.
This study tests a smoking cessation program designed for adults who are very sensitive to anxiety (like feeling panicky about physical symptoms). It takes place at local YMCA centers and aims to help you quit smoking through a community-based approach.
This study tests whether a virtual reality (VR) program can measure how your brain pays attention to smoking cues. It also involves taking a medication called varenicline (Chantix) to see if it reduces cravings. You may be eligible if you are a daily smoker, have been smoking for at least 3 years, and are not ready to quit in the next month.
This study tests if a medication used for type 2 diabetes (GLP-1 receptor agonists) can also reduce smoking in men with diabetes who smoke. If you qualify, you may receive this drug or a standard diabetes pill to see if it helps you smoke less.
This study tests whether a medication called varenicline (or a placebo) can help people who use both tobacco and cannabis to quit or cut back. It takes place in South Carolina and lasts 12 weeks.
Hear when a new Tobacco Dependence trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.